KLK4 and dilated cardiomyopathy: Interestingly, kallikrein-deficient transgenic mice develop a severe dilated cardiomyopathy (Meneton, 2001), which does not seem to be a consequence of the reduced bradykinin activation (Pesquero, 2000), suggesting additional physiological roles of kallikreins in the heart.